Ketamine has been used primarily as an anesthetic since the 1960s. Recently, it has been shown in some individuals to dramatically improve the symptoms of patients with severe depression, especially those with suicidal thoughts. Its effect can be fast acting in relieving suicidal thoughts and the severity of depression. Currently, we are able to offer this treatment intravenously, although an option to administer it intra-nasally is anticipated in the near future.
Because ketamine is not FDA-approved for the treatment of depression, it is not covered by insurance and requires an out-of-pocket payment.